Caitong International Asset Management Co., LTD Tg Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 3,106 shares of TGTX stock, worth $95,385. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,106
Previous 3,106
-0.0%
Holding current value
$95,385
Previous $93.5 Million
-0.0%
% of portfolio
0.09%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
371Shares Held
85.9MCall Options Held
3.64MPut Options Held
2.59M-
Vanguard Group Inc Valley Forge, PA15.6MShares$479 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$350 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$283 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$98.1 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$85.8 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.46B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...